anticancer therapeutic (J2H Biotech)

N/A

Report date: 2025/01/26 18:03:58
NME

Base Information

Drug Nameanticancer therapeutic (J2H Biotech)
Drug Alias Nameanticancer therapeutic (Institut Pasteur Korea)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInstitut Pasteur Korea
China Registration ClassN/A

Develop Information

Active CompaniesJ2H Biotech
Inactive CompaniesInstitut Pasteur Korea
Active IndicationsLiver Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A